Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

254
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
254
Drug Regulation01:25

Drug Regulation

1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

349
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349
Drug Delivery: Overview01:16

Drug Delivery: Overview

427
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
427
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

178
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formulation optimization and biodistribution of epigallocatechin gallate phospholipid complex-loaded NLCs for rheumatoid arthritis treatment.

Journal of liposome research·2025
Same author

Advances in research and applications of Epigallocatechin gallate: from green tea to therapeutic gold.

Journal of food science and technology·2025
Same author

Regulatory challenges and opportunities in cell-based therapies: overcoming barriers to advancement and patient care.

Regenerative medicine·2025
Same author

Advancing nanomedicine for military cold-zone operations: a global perspective on innovations in nanomedicine and future directions.

International journal of biometeorology·2025
Same author

Correction: Bromelain: a review of its mechanisms, pharmacological effects and potential applications.

Food & function·2025
Same author

Development and <i>in vivo</i> biodistribution of folate-targeted nanolipid system for erlotinib in breast cancer treatment.

Nanomedicine (London, England)·2025

Related Experiment Video

Updated: Sep 15, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.2K

Regulating nanomedicines: challenges, opportunities, and the path forward.

Bharti Mangla1, Pankaj Kumar2, Shamama Javed3

  • 1Department of Pharmaceutics, Institute of Pharmaceutical Research, GLA University, Mathura, India.

Nanomedicine (London, England)
|July 14, 2025
PubMed
Summary

Advancements in nanomedicine face hurdles due to unclear regulations. Establishing a synchronized global framework is crucial for the safe innovation and clinical translation of nanoparticle-based therapies.

Keywords:
Nanomedicinechallengesclinical trialsregulationsregulatory approaches

More Related Videos

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.4K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

Related Experiment Videos

Last Updated: Sep 15, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.2K
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.4K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K

Area of Science:

  • Nanotechnology
  • Pharmaceutical Sciences
  • Regulatory Science

Background:

  • Nanomedicines have advanced significantly, with many nanocarriers entering clinical use.
  • However, challenges in biocompatibility, nanotoxicology, and regulatory oversight hinder clinical translation.
  • The lack of a well-defined regulatory framework poses significant challenges for the pharmaceutical and healthcare industries.

Purpose of the Study:

  • To discuss key challenges in nanomedicine development and clinical translation.
  • To highlight regulatory gaps and barriers in nanomedicine oversight.
  • To emphasize the need for a globally synchronized regulatory framework.

Main Methods:

  • Review of existing literature on nanomedicine advancements and clinical applications.
  • Analysis of regulatory frameworks and their limitations across different countries.
  • Comparison of barriers to regulatory systems for nanomedicine.

Main Results:

  • Significant progress in nanomedicine is hampered by a lack of clear and effective nanotechnology regulations.
  • Regulatory gaps prevent manufacturers, legislators, and the public from properly assessing risks and safety.
  • Lack of international consensus impedes research and development (R&D) and future adoption of nanomedicines.

Conclusions:

  • There is an urgent need for a coherent and globally synchronized regulatory framework for nanomedicines.
  • Establishing such a framework will facilitate innovation, ensure safety and efficacy, and promote the advancement of nanomedicine.
  • Addressing regulatory challenges is critical for the successful clinical translation and widespread adoption of nanomedicine interventions.